Table 4. The intensity of the absorption bands in the IR spectra of saliva of patients with breast cancer and the control group.
Wavelength, cm-1 |
Control (female), n=58 |
Breast Cancer, n=50 |
p-value |
Δ, % |
970 |
17.9 [12.1; 23.8] |
9.3 [6.8; 17.5] |
0.0001* |
-48.1 |
1082 |
52.3 [42.9; 63.9] |
31.7 [22.7; 42.9] |
0.0000* |
-39.4 |
1180 |
32.4 [25.3; 38.4] |
20.7 [13.9; 29.6] |
0.0000* |
-36.1 |
1400 |
44.6 [36.8; 56.4] |
44.8 [28.9; 60.7] |
0.4957 |
+0.4 |
1460 |
31.2 [25.9; 37.5] |
24.2 [15.7; 31.2] |
0.0013* |
-22.4 |
1735 |
13.8 [9.5; 18.9] |
9.6 [7.6; 13.3] |
0.0009* |
-30.4 |
2850 |
38.0 [28.6; 47.9] |
40.8 [30.7; 54.9] |
0.2009 |
+7.4 |
2875 |
39.6 [29.9; 50.4] |
41.9 [31.3; 58.1] |
0.2492 |
+5.8 |
2930 |
49.2 [38.6; 60.6] |
52.9 [36.5; 69.3] |
0.3823 |
+7.5 |
2950 |
49.9 [38.8; 62.3] |
52.8 [36.3; 70.4] |
0.4704 |
+5.8 |
I2950/2875 |
1.24 [1.21; 1.27] |
1.20 [1.17; 1.23] |
0.0000* |
-3.5 |
I1400/1460 |
1.45 [1.26; 1.77] |
1.79 [1.59; 1.99] |
0.0000* |
+23.1 |
I2850/1735 |
2.71 [1.86; 3.85] |
4.52 [2.79; 6.03] |
0.0000* |
+66.8 |
Note. *– the differences are statistically significant, р ˂ 0.05